(+961) 1 421 000 ext 71911411 jad.wakim2@usj.edu.lb
Dr Jad Wakim is a Hematologist-Oncologist trained at the University of Texas Southwestern its NCI-designated Comprehensive Cancer Center. He is double American Board Certified in Medical Oncology Hematology. Dr. Wakim was the Director of Sweetwater Cancer Center in Rock Springs, WY for 5 years, affiliated with the Huntsman Cancer Institute, before moving back to his native Lebanon where he joined Hotel-Dieu de France University Hospital Clemenceau Medical Center Affiliated with John Hopkins International. He is a lecturer at the University of Utah Saint Joseph University Faculty of Medicine. He has earned numerous awards for clinical achievements and presentations, and has published many papers and book chapters
| Diplôme | Université | Pays | Année |
|---|---|---|---|
| American Board of Medical Oncology | ABIM/ABMS (American Board of Medical Specialties) | Etats-Unis | 2012 |
| American Board of Hematology | ABIM/ABMS (American Board of Medical Specialties) | Etats-Unis | 2012 |
| Hematology-Oncology Fellowship | University of Texas Southwestern Medical Center | Etats-Unis | 2012 |
| Internal Medicine Chief Residency | SUNY Upstate Medical University | Etats-Unis | 2009 |
| Internal Medicine Residency | SUNY Upstate Medical University | Etats-Unis | 2008 |
| American Board of Internal Medicine | ABIM (American Board of Internal Medicine) | Etats-Unis | 2008 |
| MD | Université Saint-Joseph de Beyrouth | Liban | 2004 |
| Enseignement universitaire hors USJ | Pays | Etablissement | Date début | Date fin |
|---|---|---|---|---|
| Internal Medicine & Hematology-Oncology Clinical Instructor, University of Utah, Huntsman Cancer Institute | Etats-Unis | University of Utah, Huntsman Cancer Institute | 01/03/2015 | 30/06/2018 |
| Internal Medicine Chief Resident, SUNY Upstate Medical University Hospital | Etats-Unis | SUNY Upstate Medical University Hospital | 01/07/2008 | 30/06/2009 |
| Expérience professionnelle | Organisation | Date début | Date fin |
|---|---|---|---|
| Hematologist-Oncologist, Northern Light Health-Eastern Maine Medical Center, Bangor, ME, USA | Northern Light Health-Eastern Maine Medical Center, Bangor, ME | 01/01/2022 | 30/09/2024 |
| Hematologist-Oncologist, St Michael Hospital Cancer Center, Texarkana, TX, USA | St Michael Hospital Cancer Center, Texarkana, TX, USA | 07/01/2021 | 30/06/2022 |
| Hematologist-Oncologist, Hotel-Dieu de France University Hospital | Hotel-Dieu de France University Hospital | 01/04/2018 | 11/11/2024 |
| Hematologist-Oncologist, Clemenceau Medical Center | Clemenceau Medical Center | 01/10/2017 | 11/11/2024 |
| Medical Director, Hematologist-Oncologist, Sweetwater Regional Cancer Center, an Affiliate of Huntsman Cancer Institute, University of Utah, NCI-Designated Comprehensive Cancer Center | Sweetwater Regional Cancer Center, an Affiliate of Huntsman Cancer Institute, University of Utah, NCI-Designated Comprehensive Cancer Center | 01/08/2012 | 30/09/2017 |
Médecine et Santé
Targeted Therapies Immunotherapy: Neuro, ENT, Breast, Gynecological, Pulmonary, Digestive, Urinary, Sarcomas, Dermatology, Benign Malignant Hematology
Genetic markers of chronic lymphocytic leukemia: a retrospective study of 312 patients from a reference center in Lebanon. Future Oncology 2023 Sep19(29):1991-2002. Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey. Future Oncology 2021 Nov 17(31):4071-4079. Helou S., Helou E., Abou-Khalil V., Wakim J., et al. The effect of the COVID-19 pandemic on physicians’ use perception of telehealth: The case of Lebanon. Int. J. Environ. Res. Public Health 2020, 17, 4866 Chaudary P., Wakim J., Khadim H., Karumbaiah KK., Gajra A. Acquired factor X deficiency in systemic amyloidosis: management of two cases. Haemophilia, 2013 Nov 19(6): e375-6. Wakim JJ., Levenson BM., Matthews D., Naina H. Management of an unusual case of intravascular large B-cell lymphoma of the penis, prostate, bones with CNS relapse. Journal of Clinical Oncology, 2013 June 1031(17):e288-9. Wakim JJ., Tirado CA., Dowell J., and Chen W. The first case of Philadelphia-negative acute promyelocytic leukemia following imatinib for chronic myeloid leukemia. Cancer Genetics and Cytogenetics, 2012 March;205(3): p124-127. Wakim JJ. and Tirado CA (January 2012). Acute promyelocytic leukemia lacking the classic translocation t(15;17). In: Koschmieder, S. and Krug, U. (Editors). Myeloid Leukemia – Clinical Diagnosis and Treatment. Chapter 12, p219-234. Intech. Wakim JJ., Tirado CA., Chen W., and Collins R. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Leukemia Research, 2011 Sep;35(9):e151-3